HLA-B27 and the seronegative spondyloarthropathies

American Journal of the Medical Sciences

Volumn 316, Issue 4, 1998, Pages 239-249

  Reveille, John D ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Ankylosing spondylitis; Hereditary markers; HLA B27; Seronegative spondyloarthropathies

Indexed keywords

HLA B27 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CONFERENCE PAPER; ETHNIC DIFFERENCE; HEREDITY; HUMAN; PATHOGENESIS; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REITER SYNDROME; SEROCONVERSION; SPONDYLOARTHROPATHY; STRUCTURE ACTIVITY RELATION;

EID: 0031709588     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-199810000-00004     Document Type: Conference Paper

References (132)

1. Schlosstein L, Terasaki PI, Bluestone R, Pearson CM. High association of an HL-A antigen, W27, with ankylosing spondylitis. N Engl J Med. 1972;288:704-6.
2. Brewerton DA, Hart FD, Nichols A, Caffrey M, James DCO, Sturrock RD. Ankylosing spondylitis and HL-A27. Lancet. 1973;1:904-7.
3. McClusky OE, Lordon RE, Arnett FC Jr. HL-A 27 in Reiters syndrome and psoriatic arthritis: a genetic factor in disease susceptibility and expression. J Rheumatol. 1974;1:263-8.
4. Morris R, Metzger AL, Bluestone R, Terasaki PI. HLA W27: a clue to the diagnosis and pathogenesis of Reiter's syndrome. N Engl J Med. 1974;290:554-6.
5. Brewerton DA, Nicholls A, Oates JK, James DCO. Reiter's disease and HLA-27. Lancet. 1973;2:996-8.
6. Brewerton DA, Caffrey M, Nicholls A, Walters D, James DCO. HL-A 27 and arthropathies associated with ulcerative colitis and psoriasis. Lancet. 1974; 1:956-7.
7. Metzger AL, Morris RI, Bluestone R, Terasaki PI. HLA W27 in psoriatic arthropathy. Arthritis Rheum. 1975;18:111-5.
8. Dekker-Saeys BJ, Meuwissen SGM, Van Den Berg-Loonen EM, DeHaas WHD, Meijers KAF, Tytgat GNJ. Clinical characteristics and results of histocompatibility typing (HLA B27) in 50 patients with both ankylosing spondylitis and inflammatory bowel disease. Ann Rheum Dis. 1978;37:36-41.
9. Russell AS. Arthritis, inflammatory bowel disease, and histocompatibility antigens. Ann Intern Med. 1977;86:820-1.
10. Ezquerra A, Bragado R, Vega MA, Strominger JL, Woody J, Lopez de Castro JA. Primary structure of pa-pain-solubilized human histocompatibility antigen HLA-B27. Biochemistry. 1985;24:1733-41.
11. Weiss EH, Kuon W, Dorner C, Lang M, Riethmuller G. Organization, sequence and expression of the HLA-B27 gene: a molecular approach to analyze HLA and disease associations. Immunobiology. 1985;170:367-80.
12. Madden DR, Gorga JC, Strominger JL, Wiley DC. The structure of HLA-B27 reveals nonamer self-peptides bound in an extended conformation. Nature. 1991;353:321-5.
13. Benjamin R, Parham P. Guilt by association: HLA-B27 and ankylosing spondylitis. Immunology Today. 1990; 11:137-42.
14. Buxton SE, Benjamin RJ, Clayberger C, Parham P, Krensky AM. Anchoring pockets in human histocompatibility complex leukocyte antigen (HLA) class I molecules: analysis of the conserved B ("45") pocket of HLA-B27. J Exp Med. 1992;175:809-20.
15. Madden DR, Gorga JC, Strominger JL, Wiley DC. The three-dimensional structure of HLA-B27 at 2.1 Å resolution suggests a general mechanism for tight peptide binding to MHC. Cell. 1992;70:1035-48.
16. Jardetzky TS, Lane WS, Robinson RA, Madden DR, Wiley DC. Identification of self peptides bound to purified HLA-B27. Nature. 1991;353:326-9.
17. Ren EC, Koh WH, Sim D, Boey ML, Wee GB, Chan SH. Possible protective role of HLA-B*2706 for ankylosing spondylitis. Tissue Antigens. 1997;49:67-9.
18. Krylov M, Erdesz S, Alexeeva L, Benevolenskaya L, Reveille JD, Arnett FC. HLA class II and HLA-B27 oligotyping in two Siberian native population groups. Tissue Antigens. 1995;46:382-6.
19. Choo SY, Fan LA, Hansen JA. A novel HLA-B27 allele maps B27 allospecificity to the region around position 70 in the alpha 1 domain. J Immunol. 1991;147:174-80.
20. Choo SY, Antonelli P, Nisperos B, Nepom GT, Hansen JA. Six variants of HLA-B27 identified by isoelectric focussing. Immunogenetics. 1986;23:24-9.
21. Reveille JD, Fraser PA, Taurog JD, Pollack M, Ahearn JM, Khan MA, Appleyard J, Arnett FC. HLA-B27 subtypes in African Americans with spondyloarthropathy (SpA). Arthritis Rheum. 1996;39(suppl):S204(Abstract).
22. MacLean IL, Iqball S, Woo P, Keat AC, Hughes RA, Kingsley GH, Knight SC. HLA-B27 subtypes in the spondarthropathies. Clin Exp Immunol. 1993;91:214-9.
23. Breur-Vriesendorp BS, Neefjes JC, Huis B, van Seventer GA, Ploegh HL, Ivanyi P. Identification of new B27 subtypes (B27C and B27D) prevalent in Oriental populations. Hum Immunol. 1986;16:163.
24. Lopez-Larrea C, Sujirachato K, Mehra NK, Chiewsilp P, Isarangkura D, Kanga U, et al. HLA-B27 subtypes in Asian patients with ankylosing spondylitis. Tissue Antigens. 1995;45:169-76.
25. Rojo S, Aparicio P, Hansen JA, Choo SY, Lopez de Castro JA. Structural analysis of an HLA-B27 functional variant, B27d, detected in American Blacks. J Immunol. 1987;139:3396-3401.
26. Hill AVS, Allsopp CEM, Kwiatkowski D, Anstey NM, Greenwood BM, McMichael AJ. HLA class I typing by PCR: HLA-B27 and an African B27 subtype. Lancet. 1991;337:640-2.
27. Gonalez-Roces S, Alvarez MV, Gonzalez S, Dieye A, Makni H, Woodfield DG, et al. HLA-B27 polymorphism and worldwide susceptibility to ankylosing spondylitis. Tissue Antigens. 1997;49:116-23.
28. Hildebrand WH, Domena JD, Shen SY, Marsh SG, Bunce M, Guttridge MG, et al. The HLA-B7Qui antigen is encoded by a new subtype of HLA-B27 (B*2708). Tissue Antigens. 1994;44:47-51.
29. D'Amato M, Fiorillo MT, Carcassi C, Mathieu A, Zuccarelli A, Bitti PP, et al. Relevance of residue 116 of HLA-B27 in determining susceptibility to ankylosing spondylitis. Eur J Immunol. 1995;25:3199-201.
30. Hasegawa T, Ogawa A, Suguhara Y, Moriyama Y, Nanzai H, Tawara K, Tokunaga K, et al. A novel HLA-B27 allele (B*2711) encoding an antigen reacting with both B27- and B40-specific antisera. Tissue Antigens. 1997;49:649-52.
31. Rotzschke O, Falk K, Stevanovic S, Gnau V, Jung G, Rammensee HG. Dominant aromatic/aliphatic C-terminal anchor in HLA-B*2702 and B*2705 peptide motifs. Immunogenetics. 1994;39:74-7.
32. Raghavan M, Lebron JA, Johnson JL, Bjorkman PJ. Extended repertoire of permissible peptide ligands for HLA-B*2702. Protein Sci. 1996;5:2080-8.
33. Garcia F, Marina A, Lopez de Castro JA. Lack of carboxyl-terminal tyrosine distinguishes the B*2706-bound peptide repertoire from those of B*2704 and other HLA-B27 subtypes associated with ankylosing spondylitis. Tissue Antigens. 1997;49:215-21.
34. Nasution AR, Mardjuadi A, Kunmartini S, Suryadhana NG, Setyohadi B, Sudarsono D, et al. HLA-B27 subtypes positively and negatively associated with spondyloarthropathy. J Rheumatol. 1997;24:1111-4.
35. Breur-Vriesendorp BS, Dekker-Saeys AJ, Ivanyi PI. Distribution of HLA-B27 subtypes in patients with ankylosing spondylitis: the disease is associated with a common determinant of the various B27 molecules. Ann Rheum Dis. 1987;46:353-6.
36. Baech J, Schmidt-Olson S, Steffensen R, Varming K, Grunnet N, Jersild C. Frequency of HLA-B27 subtypes in a Danish population and in Danish patients with ankylosing spondylitis. Tissue Antigens. 1997;49:499-502.
37. Gonzalez-Roces S, Brautbar C, Pena M, Dominguez O, Coto E, Alvarez V, et al. Molecular analysis of HLA-B27 haplotypes in Caucasoids: frequencies of B27-Cw in Jewish and Spanish populations. Hum Immunol. 1994;41:127-34.
38. Frankenberger B, Breitkopf S, Albert E, Scholz S, Keller E, Schattenkirchner M, et al. Routine molecular genotyping of HLA-B27 in spondyloarthropathies overcomes the obstacles of serological typing and reveals an increased B*2702 frequency in ankylosing spondylitis. J Rheumatol. 1997;24:899-903.
39. Kanga U, Mehra NK, Larrea CL, Lardy NM, Kumar A, Feltkamp TEW. Seronegative spondyloarthropathies and HLA-B27 subtypes: a study in Asian Indians. Clin Rheum. 1996;15(suppl):13-8.
40. von Boehmer H, Kisielow P. Self-nonself discrimination by T cells. Science. 1990;248:1369-72.
41. Monaco JJ, Nandi D. The genetics of proteasomes and antigen processing. Ann Rev Immunol. 1995;29:729-54.
42. Glynne R, Powis SH, Beck S, Kelly A, Kerr L, Trowsdale J. A proteasome-related gene between the two ABC transporter loci in the class II region of the human MHC. Nature. 1991;353:357-60.
43. Spies T, Bresnahan M, Bahram S, Arnold D, Blanck G, Mellins E, et al. A gene in the human major histocompatibility complex class II region controlling the class I antigen presentation pathway. Nature. 1990;348:744-7.
44. Trowsdale J, Hanson I, Mockridge I, Beck S, Townsend A, Kelly A. Sequences encoded in the class II region of the MHC related to the 'ABC' super family of transporters. Nature. 1990;348:741-4.
45. Deverson EV, Gow IR, Coadwell WJ, Monaco JJ, Butcher GW, Howard JD. MHC class II region encoding proteins related to the multidrug resistance family of transmembrane transporters. Nature. 1990;348:738-41.
46. Powis SH, Mockridge I, Kelly A, Kerr L, Glynne R, Gileadi U, et al. Polymorphism in a second ABC transporter gene located within the class II region of the human major histocompatibility complex. Proc Natl Acad Sci U S A. 1992;89:1463-7.
47. Barron KS, Carrington M, Reveille JD, Robinson MA. Polymorphism in TAP genes in Reiter's syndrome. Arthritis Rheum. 1993;36:S135 (Abstract).
48. Burney RO, Pile KD, Gibson K, Calin A, Kennedy LG, Sinnott PJ, et al. Analysis of the MHC class II encoded components of the HLA class I antigen processing pathway in ankylosing spondylitis. Ann Rheum Dis. 1994;53:58-60.
49. Sonozaki H, Seki H, Chang S, Okuyama M, Juji T. Human lymphocyte antigen, HL-A27, in Japanese patients with ankylosing spondylitis. Tissue Antigens. 1975;5:131-6.
50. Chan SH, Satkunananthan K, Wee GB, Seinivan N, Chacha P. HLA-B27 and Chinese ankylosing spondylitis. Singapore Med J. 1980;21:710-2.
51. Gofton JP, Chalmers A, Price GE, Reeve CE. HL-A27 and ankylosing spondylitis in B.C. Indians. J Rheumatol. 1975;2:314-8.
52. Fraga A, Gorodezky C, Lavalle C, Castro-Escobar LE, Magana L, Escobar-Guiterrez A. HLA-B27 in Mexican patients with ankylosing spondylitis. Arthritis Rheum. 1979;22:302-3.
53. Good AE, Kawanishi H, Schultz JS. HLA B27 in Blacks with ankylosing spondylitis or Reiter's syndrome. N Engl J Med. 1976;294:166-7.
54. Sengupta S, Sehgal S, Aikat BK, Deodhar SD, James DC. HLA-B27 in ankylosing spondylitis in India. Lancet. 1977;1:1209-10.
55. Davatchi F, Nikbin B, Ala F. Histocompatibility antigen (HLA) in rheumatic diseases in Iran. J Rheumatol. 1977;3(suppl4):36-8.
56. Al-Rawi ZS, Al-Shakarchi HA, Hasan F, Thewaini AJ. Ankylosing spondylitis and its association with the histocompatibility antigen HLA-B27: an epidemiological and clinical study. Rheumatol Rehabil. 1978;17:72-5.
57. Brautbar C, Porat S, Nelken D, Gabriel KR, Cohen T. HLA-B27 and ankylosing spondylitis in the Israeli population. J Rheumatol. 1977;4(suppl 3):24-32.
58. Oen K, Postl B, Chalmers IM, Ling N, Schroeder ML, Barager FD, et al. Rheumatic diseases in an Inuit population. Arthritis Rheum. 1986;29:65-74.
59. Alexeeva L, Krylov M, Vturin V, Mylov N, Erdesz S, Benevolenskaya L. Prevalence of Spondyloarthropathies and HLA-B27 in the native population of Chukotka, Russia. J Rheumatol. 1994;21:2298-300.
60. Hochberg MC, Bias WB, Arnett FC. Family studies in HLA-B27 associated arthritis. Medicine. 1978;57:463-73.
61. Lochead JA, Chalmers IM, Marshall WH, Larsen B, Skanes VM, Payne RH, Barnard JM. HLA-B27 haplotypes in family studies of ankylosing spondylitis. Arthritis Rheum. 1983;26:1011-6.
62. Rubin LA, Amos CI, Wade JA, Martin JR, Bale SJ, Little AH, et al. Investigating the genetic basis for ankylosing spondylitis: linkage studies with the major histocompatibility complex region. Arthritis Rheum. 1994;37:1212-20.
63. Reveille JD, Suarez-Almazor ME, Russell AS, Go RCP, Appleyard J, Barger BO, Acton RT, et al. HLA in ankylosing spondylitis. Is HLA-B27 the only MHC gene involved in disease pathogenesis. Semin Arthritis Rheum. 1994; 23:295-309.
64. Brown MA, Kennedy GL, MacGregor AJ, Drake C, Duncan E, Shatford JL, et al. Susceptibility to ankylosing spondylitis in twins-the role of genes, HLA, and the environment. Arthritis Rheum. 1997;40:1823-8.
65. van der Linden SM, Valkenburg HA, deJongh BM, Cats A. The risk of developing ankylosing spondylitis in HLA-B27 positive individuals. A comparison of relatives of spondylitis patients with the general population. Arthritis Rheum. 1984;27:241-9.
66. Robinson WP, van der Linden SM, Khan MA, Rentsch HU, Cats A, Russell A, Thomson G. HLA-Bw60 increases susceptibility to ankylosing spondylitis in HLA-B27+ patients. Arthritis Rheum. 1989;32:1135-41.
67. Maksymowych WP, Wessler A, Schmitt-Egenolf M, Suarez-Almazor M, Ritzel G, von Borstel RC, et al. Polymorphism in an HLA linked proteasome gene influences phenotypic expression of disease in HLA-B27 positive individuals. J Rheumatol. 1994;21:665-9.
68. Suarez-Almazor ME, Russell AS, LeClercq S. Ankylosing spondylitis in families with two distinct B27 haplotypes: a selective association. Arthritis Rheum. 1986;29:1510-4.
69. Arnett FC, Schacter BZ, Hochberg MC, Hsu SH, Bias WB. Homozygosity for HLA-B27. Impact on rheumatic disease expression in two families. Arthritis Rheum. 1977;20:797-804.
70. Ploski R, Flato B, Vinje O, Maksymowych W, Forre O, Thorsby E. Association to HLA-DRB1*08, HLA-DPB1*0301 and homozygosity for an HLA-linked proteasome gene in juvenile ankylosing spondylitis. Human Immunol. 1995;44:88-96.
71. Monowarul Islam SM, Numaga J, Fujino Y, Masuda K, Ohda H, Hirata R, et al. HLA-DR8 and acute anterior uveitis in ankylosing spondylitis. Arthritis Rheum. 1995;38:547-50.
72. Ploski R, Maksymowych W, Forre O. HLA-DR8 and susceptibility to acute anterior uveitis in ankylosing spondylitis: comment on the article by Monowarul Islam et al (letter). Arthritis Rheum. 1996;39:351-2.
73. Armstrong RD, Panayi GS, Welsh KI. Histocompatibility antigens in psoriasis, psoriatic arthropathy, and ankylosing spondylitis. Ann Rheum Dis. 1983;42:142-6.
74. Sanmarti R, Ercilla MG, Brancos MA, Cid MC, Collado A, Rotes-Querol J. HLA class II antigens (DR, DQ loci) and peripheral arthritis in ankylosing spondylitis. Ann Rheum Dis. 1987;46:497-500.
75. Khan MA, Braun WE, Kushner I, Grecek DE, Muir WA, Steinberg AG. HLA B27 in ankylosing spondylitis: differences in frequency and relative risk in American Blacks and Caucasians. J Rheumatol. 1977;4:39-43.
76. Chalmers IM. Ankylosing spondylitis in African Blacks. Arthritis Rheum. 1980;23:1366-70.
77. Khan MA, Askari AD, Braun WE, Aponte CJ. Low association of HLA-B27 with Reiter's syndrome in blacks. Ann Intern Med. 1979;90:202-3.
78. Arnett FCJ, Hochberg MC, Bias WB. Cross-reactive HLA antigens in B27-negative Reiter's syndrome and sacroiliitis. Johns Hopkins Med J. 1977;141:193-7.
79. Khan MA, Kushner I, Braun WE. A subgroup of ankylosing spondylitis associated with HLA-B7 in American blacks. Arthritis Rheum. 1978;21:528-30.
80. Cedoz JP, Wendling D, Viel JF. The B7 cross reactive group and spondyloarthropathies: an epidemiological approach. J Rheumatol. 1995;22:1884-90.
81. Khan MA, Kushner I, Braun WE. Comparison of clinical features of HLA-B27 positive and negative patients with ankylosing spondylitis. Arthritis Rheum. 1977;60:909-12.
82. Edmonds J, Bashir H, Thomson G, Carbonara AO. HLA-B27-negative ankylosing spondylitis, histocompatibility testing. In: Albert ED, ed. Histocompatibility Testing. Berlin, Heidelberg: Springer-Verlag; 1984:388.
83. Yamaguchi A, Tsuchiya N, Mitsui H, Shiota M, Ogawa A, Tokunaga K, et al. Association of HLA-B39 with HLA-B27-negative ankylosing spondylitis and pauciarticular juvenile rheumatoid arthritis in Japanese patients: evidence for a role of the peptide-anchoring B pocket. Arthritis Rheum. 1995;38:1672-7.
84. Leirsalo M, Skylv G, Kousa M, Voipo-Pulkki LM, Suoranta H, Nissila M, et al. Followup study on patients with Reiter's disease and reactive arthritis, with special reference to HLA-B27. Arthritis Rheum. 1982;25:249-58.
85. Calin A, Fries JF. An "experimental" epidemic of Reiter's syndrome revisited: follow-up evidence on genetic and environmental factors. Ann Intern Med. 1976;84:564-6.
86. Svejgaard A, Staub-Nielsen L, Svejgaard E, Kissmeyer-Nielsen F, Hjortshoj A, Zachariae H. HL-A in psoriasis vulgaris and pustular psoriasis-population and family studies. Br J Dermatol. 1974;91:145-53.
87. Kantor SM, Hsu SH, Bias WB, Arnett FC. Clinical and immunogenetic subsets of psoriatic arthritis. Clinical Exp Rheumatol. 1984;2:105-9.
88. Murray C, Mann DL, Gerber LN, Barth W, Perlmann S, Decker JL, Nigra TP. Histocompatibility alloantigens in psoriasis and psoriatic arthritis. J Clin Invest. 1980;66:670-5.
89. Kammer GM, Soter NA, Gibson DJ, Schur PH. Psoriatic arthritis: a clinical, immunological and HLA study of 100 patients. Semin Arthritis Rheum. 1979;9:75-97.
90. Espinoza LR, Vasey FB, Oh JH, Wilkinson R, Osterland CK. Association between HLA-BW38 and peripheral psoriatic arthritis. Arthritis Rheum. 1978;21:72-5.
91. Rachelefsk GS, Terasaki PI, Katz R, Stiehm ER. Increased prevalence of W27 in juvenile rheumatoid arthritis. N Engl J Med. 1974;290:892-3.
92. Edmonds J, Morris RI, Metzger AL, Bluestone R, Terasaki PI, Ansell B, Bywaters EGL. Follow-up study of juvenile chronic polyarthritis with particular reference to histocompatibility antigen W.27. Ann Rheum Dis. 1974;33:289-92.
93. Arnett FC, Bias WB, Stevens MB. Juvenile-onset chronic arthritis: clinical and roentgenographic features of a unique HLA-B27 subset. Am J Med. 1980;69:369-76.
94. Burgos-Vargas R, Vasquez-Mellado J. The early clinical recognition of juvenile-onset ankylosing spondylitis and its differentiation from juvenile rheumatoid arthritis. Arthritis Rheum. 1995;38:835-44.
95. deCeulaer K, van der Linden JMJP, Cats A. Sausage-like toes (dactylitis) and HLA B27. J Rheumatol. 1977;4:66-9.
96. Woodrow JC, Mapstone R, Anderson J, Usher N. HL-A27 and anterior uveitis. Tissue Antigens. 1975;6:116-20.
97. Bergfeldt L, Insulander P, Lindblom D, Moller E, Edhag O. HLA-B27: an important genetic risk factor for lone aortic regurgitation and severe conduction system abnormalities. Am J Med. 1988;85:12-8.
98. Bergfeldt L, Edhag O, Rajs J. HLA-B27 associated heart disease. Am J Med. 1984;77:961-7.
99. Bergfeldt L. HLA-B27-associated rheumatic diseases with severe cardiac bradyarrhythmias. Am J Med. 1983;75:210-5.
100. Kaslow RA, Carrington M, Apply R, Park L, Munoz A, Saah AJ, et al. Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nature Medicine. 1996;2:395-6.
101. McNeil AJ, Yap PL, Gore SM, Brettle RP, McColl M, Wyld R, et al. Association of HLA types A1-B8-DR3 and B27 with rapid and slow progression of HIV disease. Q J Med. 1996;89:177-85.
102. Goulder PJR, Phillips RE, Colbert RA, McAdam S, Ogg G, Nowak MA, et al. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nature Medicine. 1997;3:212-7.
103. Reveille JD, Conant MA, Duvic M. HIV-associated psoriasis, psoriatic arthritis and Reiter's syndrome: a disease continuum? Arthritis Rheum. 1990;33:1574-8.
104. Brown M, Wordsworth P.q Predisposing factors to spondyloarthropathies. Current Opin Rheumatol. 1997;9:308-14.
105. Schwimmbeck PL, Yu DTY, Oldstone MBA. Autoantibodies to HLA B27 in the sera of HLA B27 patients with ankylosing spondylitis and Reiter's syndrome: molecular mimicry with Klebsiella pneumoniae as potential mechanism of autoimmune disease. J Exp Med. 1987;166:173-81.
106. Lahesmaa R, Skurnik M, Granfors K, Mottonen T, Saario R, Toivanen A, Toivanen P. Molecular mimicry in the pathogenesis of spondylarthropathies: a critical appraisal of cross-reactivity between microbial antigens and HLA-B27. Br J Rheumatol. 1992;31:221-9.
107. Steiglitz H, Fosmire S, Lipsky P. Identification of a 2-Md plasmid from Shigella flexneri associated with reactive arthritis. Arthritis Rheum. 1989;32:937-46.
108. Tsuchiya N, Husby G, Williams RC Jr, Stieglitz H, Lipsky PE, Inman RD. Autoantibodies to the HLA-B27 sequence cross-react with the hypothetical peptide from the arthritis-associated Shigella plasmid. J Clin Invest. 1990;86:1193-203.
109. Tsuchiya N, Husby G, Williams RC, Jr. Antibodies to the peptide from the plasmid-coded Yersinia outer membrane protein (YOP1) in patients with ankylosing spondylitis. Clin Exp Immunol. 1990;82:493-8.
110. Scofield RH, Warren WL, Koelsch G, Harley JB. A hypothesis for the HLA-B27 immune dysregulation in spondyloarthropathy: contributions from enteric organisms, B27 structure, peptides bound by B27, and convergent evolution. Proc Natl Acad Sci U S A. 1993;90:9330-4.
111. Scofield RH, Warren WL, Gross T, Harley JB. HLA-B27 binding of peptide from its own sequence and similar peptides from bacteria: implications for spondyloarthropathies. Lancet. 1995;345:1542-4.
112. Archer JR, Whelan MA, Badakere SS, McLean IL, Archer PV, Winrow VR. Effect of a free sulfhydryl group on expression of HLA-B27 specificity. Scand J Rheumatol. 1990;87(suppl):44-50.
113. Davenport MP. The promiscuous B27 hypothesis (letter). Lancet. 1995;346:500-1.
114. Schumacher HR, Magge S, Cherian PV, Sleckman J, Rothfuss S, Clayburne G, Sieck M. Light and electron microscopic studies on synovial membrane in Reiter's syndrome: immunocytochemical identification of chlamydial antigens in patients with early disease. Arthritis Rheum. 1988;31:937-46.
115. Merilahti-Palo R, Soderstrom K, Lahesmaa-Rantala R, Granfors K, Toivanen A. Bacterial antigens in synovial biopsy specimens in Yersinia triggered reactive arthritis. Ann Rheum Dis. 1991;50:87-90.
116. Merilahti-Palo R, Pelliniemi LJ, Granfors K, Soderstrom KO, Von Essen R, Simila A, Toivanen A. Electron microscopy and immunolabeling of Yersinia antigens in human synovial fluid cells. Clin Exp Rheumatol. 1994;12:255-9.
117. Granfors K, Jalkanen S, VonEssen R, Lahesmaa-Rantala R, Isomaki O, Pekkola-Heinoi K, et al. Yersinia antigens in synovial fluid cells from patients with reactive arthritis. N Engl J Med. 1989;320:216-21.
118. Granfors K, Jalkanen S, Lindberg AA, Maki-Ikola O, VanEssen R, Lahesmaa-Rantala R, et al. Salmonella lipopolysaccharide in synovial cells from patients with reactive arthritis. Lancet. 1990;335:685-8.
119. Laitio P, Virtala M, Salmi M, Pelliniemi LJ, Yu DT, Granfors K. HLA-B27 modulates intracellular survival of Salmonella enteritidis in human monocytic cells. Eur J Immunol. 1997;27:1331-8.
120. Hermann E, Yu DTY, Meyer zum Buschenfelde KH, Fleischer B. HLA-B27 restricted CD8 T cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis. Lancet. 1993;342:646-50.
121. Duchmann R, May E, Ackermann B, Goergen B, Meyer zum Buschenfelde KH, Marker-Hermann E. HLA-B27-restricted cytotoxic T lymphocyte responses to arthritogenic enterobacteria or self-antigens are dominated by closely related TCRBV gene segments: a study in patients with reactive arthritis. Scand J Immunol. 1996;43:101-8.
122. Hammer RE, Maika SD, Richardson JA, Tang J, Taurog JD. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27-associated human disorders. Cell. 1990;63:1099-112.
123. Geraghty DE. Structure of the HLA class I region and expresson of its resident genes. Curr Opin Immunol. 1993;5:3-7.
124. Khan MA. Clinical application of the HLA-B27 test in rheumatic diseases. Arch Intern Med. 1980;140:177-80.
125. Espinoza LR, Vasey FB, Gaylord SW, Dietz C, Bergen L, Bridgeford P, Germain BF. Histocompatibility typing in the seronegative spondyloarthropathies: a survey. Semin Arthritis Rheum. 1982;11:375-81.
126. Khan MA, Khan MK. Diagnostic value of HLA-B27 testing in ankylosing spondylitis and Reiter's syndrome. Ann Int Med. 1982;96:70-6.
127. Hawkins BR, Dawkins RL, Christiansen FT, Zilko PJ. Use of the B27 test in the diagnosis of ankylosing spondylitis: a statistical evaluation. Arthritis Rheum. 1981;24:743-6.
128. Kahn MS, van der Linden S, Kushner I, Valkenburg HA, Cats A. Spondylytic disease without radiographic evidence of sacroiliitis in relatives of HLA-B27 positive ankylosing spondylitis patients. Arthritis Rheum. 1985;28:40-3.
129. Hill ASV, Allsopp CEM, Kwiatkowski D, McMichael AJ. HLA class I typing by PCR: HLA-B27 and an African B27 subtype. Lancet. 1991;337:640-2.
130. Olerup O. HLA-B27 typing by a group-specific PCR amplification. Tissue Antigens. 1994;43:253-6.
131. Nieto A, Fraile A, Vinasco J, Martin J. HLA-B*27 typing by PCR-restriction fragment length polymorphism. Tissue Antigens. 1997;49:283-6.
132. Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC. Structure of the human class I histocompatibility antigen, HLA-A2. Nature. 1987; 329:506-12.